 LYON, France and CAMBRIDGE, Mass., Nov. 02, 2020 GLOBE NEWSWIRE -- ERYTECH Pharma Nasdaq Euronext: ERYP, a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced today that it has received financing approval s from Bpifrance and Société Générale for a total of 10 million in the form of S tate- G uaranteed L oan s Prêt s Garanti s par lEtat , or PGE in France in the context of the COVID-19 pandemic. 